216 related articles for article (PubMed ID: 8165651)
1. Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin.
Cattaneo M; Akkawat B; Kinlough-Rathbone RL; Packham MA; Cimminiello C; Mannucci PM
Thromb Haemost; 1994 Jan; 71(1):91-4. PubMed ID: 8165651
[TBL] [Abstract][Full Text] [Related]
2. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.
Cattaneo M; Canciani MT; Lecchi A; Kinlough-Rathbone RL; Packham MA; Mannucci PM; Mustard JF
Blood; 1990 Mar; 75(5):1081-6. PubMed ID: 2137716
[TBL] [Abstract][Full Text] [Related]
3. Lack of stability of aggregates after thrombin-induced reaggregation of thrombin-degranulated platelets.
Kinlough-Rathbone RL; Packham MA; Perry DW; Mustard JF; Cattaneo M
Thromb Haemost; 1992 Apr; 67(4):453-7. PubMed ID: 1631794
[TBL] [Abstract][Full Text] [Related]
4. Deaggregation of human platelets aggregated by thrombin.
Kinlough-Rathbone RL; Perry DW; Packham MA; Mustard JF
Thromb Haemost; 1985 Feb; 53(1):42-4. PubMed ID: 2986309
[TBL] [Abstract][Full Text] [Related]
5. Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate.
Cattaneo M; Akkawat B; Lecchi A; Cimminiello C; Capitanio AM; Mannucci PM
Thromb Haemost; 1991 Dec; 66(6):694-9. PubMed ID: 1665598
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the deaggregation of human and rabbit platelets.
Kinlough-Rathbone RL; Mustard JF; Perry DW; Dejana E; Cazenave JP; Packham MA; Harfenist EJ
Thromb Haemost; 1983 Jun; 49(3):162-7. PubMed ID: 6308846
[TBL] [Abstract][Full Text] [Related]
7. Effects of plasmin on rabbit platelets.
Guccione MA; Kinlough-Rathbone RL; Packham MA; Harfenist EJ; Rand ML; Greenberg JP; Perry DW; Mustard JF
Thromb Haemost; 1985 Feb; 53(1):8-14. PubMed ID: 3158094
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the deaggregation of chymotrypsin-treated human platelets aggregated by fibrinogen.
Kinlough-Rathbone RL; Mustard JF; Packham MA; Harfenist EJ
Thromb Haemost; 1983 Jun; 49(3):196-8. PubMed ID: 6410532
[TBL] [Abstract][Full Text] [Related]
9. Binding of aggregated immunoglobulins to the human platelet Fc receptors: a mechanism of platelet to platelet bridging.
Parbtani A; Clark WF; Caveney A; Reid B
Thromb Haemost; 1987 Dec; 58(4):966-70. PubMed ID: 3127922
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
11. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
12. Plasmin inhibition of thrombin-induced platelet aggregation.
Miller JL; Katz AJ; Feinstein MB
Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
[TBL] [Abstract][Full Text] [Related]
14. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
Defreyn G; Gachet C; Savi P; Driot F; Cazenave JP; Maffrand JP
Thromb Haemost; 1991 Feb; 65(2):186-90. PubMed ID: 2053105
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients.
Cattaneo M; Kinlough-Rathbone RL; Lecchi A; Bevilacqua C; Packham MA; Mustard JF
Blood; 1987 Jul; 70(1):221-6. PubMed ID: 3109523
[TBL] [Abstract][Full Text] [Related]
16. Deaggregation is an integral component of the response of platelets to ADP in vitro: kinetic studies of literature and original data.
Maayani S; Tagliente TM; Schwarz T; Craddock-Royal B; Alcala C; Marrero G; Martinez R
Platelets; 2001 Aug; 12(5):279-91. PubMed ID: 11487380
[TBL] [Abstract][Full Text] [Related]
17. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
19. Association of fibrinogen with human platelets pretreated with chymotrypsin or aggregated with ADP or thrombin: an immunocytochemical study.
Suzuki H; Kinlough-Rathbone RL; Packham MA; Yamazaki H; Mustard JF
Br J Exp Pathol; 1989 Aug; 70(4):479-88. PubMed ID: 2765399
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease.
Kinlough-Rathbone RL; Perry DW; Packham MA
Thromb Haemost; 1995 Jan; 73(1):122-5. PubMed ID: 7740483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
